Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter - Archive ouverte HAL Access content directly
Journal Articles World Journal of Urology Year : 2022

Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter

Geoffroy de Sallmard
Marie-Aimée Perrouin-Verbe
  • Function : Author
Benoit Peyronnet
  • Function : Author
Xavier Biardeau
  • Function : Author
Delphine Maucort-Boulch
Service de Biostatistiques [Lyon]
Hospices Civils de Lyon
CV
Emmanuel Chartier-Kastler
  • Function : Author
Véronique Phé
  • Function : Author
Alexia Even
  • Function : Author
Charles Joussain
  • Function : Author
Inès Dominique
  • Function : Author
Gérard Amarenco
  • Function : Author
Xavier Gamé
  • Function : Author
Christian Saussine
  • Function : Author
Alain Ruffion

Domains

Life Sciences [q-bio]

Delphine Maucort-Boulch  : Connect in order to contact the contributor

https://hal.science/hal-04151045

Submitted on : Tuesday, July 4, 2023-4:25:29 PM

Last modification on : Tuesday, March 12, 2024-1:43:43 PM

No file

Dates and versions

hal-04151045 , version 1 (04-07-2023)

Identifiers

Cite

Geoffroy de Sallmard, Marie-Aimée Perrouin-Verbe, Benoit Peyronnet, Xavier Biardeau, Delphine Maucort-Boulch, et al.. Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter. World Journal of Urology, 2022, 40 (2), pp.489-495. ⟨10.1007/s00345-021-03850-y⟩. ⟨hal-04151045⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

HCL
6 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More